C12N 2500/25
Insulin-transferrin
Official title: Insulin-transferrin; Insulin-transferrin-selenium
C12N2500/25 (Insulin-transferrin) appears on 588 US grants and 1,016 published applications in this corpus.
Search patents in C12N- Granted patents
- 588
- Published applications
- 1,016
- Assignees
- 541
- Inventors
- 1,941
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 9 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 10 | 0 |
| 1998 | 20 | 0 |
| 1999 | 17 | 0 |
| 2000 | 19 | 0 |
| 2001 | 9 | 7 |
| 2002 | 19 | 27 |
| 2003 | 14 | 43 |
| 2004 | 5 | 32 |
| 2005 | 13 | 36 |
| 2006 | 17 | 26 |
| 2007 | 14 | 34 |
| 2008 | 20 | 38 |
| 2009 | 7 | 41 |
| 2010 | 13 | 43 |
| 2011 | 18 | 46 |
| 2012 | 28 | 46 |
| 2013 | 17 | 40 |
| 2014 | 16 | 31 |
| 2015 | 30 | 31 |
| 2016 | 29 | 51 |
| 2017 | 24 | 46 |
| 2018 | 28 | 31 |
| 2019 | 26 | 44 |
| 2020 | 27 | 47 |
| 2021 | 19 | 43 |
| 2022 | 16 | 41 |
| 2023 | 17 | 61 |
| 2024 | 21 | 48 |
| 2025 | 25 | 47 |
| 2026 | 13 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population11 Aug 2026US 12,703,854 B2Ncardia B.V.
- Methods for reprogramming cells and uses thereof12 May 2026US 12,624,342 B2Genesis Technologies Limited
- Methods for preparing mesenchymal stem cells28 Apr 2026US 12,612,600 B2Allife Medicine (Beijing) Limited
- Mesenchymal stromal cells as a reprogramming source for iPSC induction31 Mar 2026US 12,590,295 B2The University of Hong Kong
- Neural stem cell-induced differential medium and induction differentiation method31 Mar 2026US 12,590,954 B2Iregene Therapeutics Ltd
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Composition for inducing direct differentiation of stem cells into corneal endothelial cells and method for inducing direct differentiation using same24 Sep 2026US 2026/0286295 A1The Asan Foundation
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
- Cells and methods of preparation3 Sep 2026US 2026/0258362 A1LIfT BioSciences Ltd
Most cited
By later US patents
- Cell culture medium with antioxidant409US 4,927,762 ACell Enterprises, Inc. · 1990
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- Adipose-derived stem cells and lattices313US 6,777,231 B1The Regents of the University of California · 2004
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Mammalian neural crest stem cells206US 5,589,376 ACalifornia Institute of Technology · 1996